Arab Finance: Arab Drug Company’s (ADCI) net profits after tax jumped 123% year on year (YoY) in the first half (H1) of fiscal year (FY) 2023/2024, according to a disclosure on January 30^th.

Net profits after tax recorded EGP 65.685 million in H1 of this FY, up from EGP 53.197 million in H1 of the previous FY.

Meanwhile, operating revenues logged a 127% YoY increase to EGP 413.897 million from EGP 324.961 million.

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.

Oriental Weavers Carpets logs 16.36% YoY lower consolidated profits in H1 2025 Updated 8/13/2025 1:55:00 PM

ALEXBANK’s profits hike 47% YoY in H1 2025 Updated 8/12/2025 2:03:00 AM

Arab Engineering Industries logs 74.6% YoY lower profits in H1 2025 Updated 8/11/2025 8:52:00 AM

Arab Drug’s net profits jump 217% YoY in FY2024/25 Updated 7/31/2025 9:23:00 AM

EGYtrans records 230% YoY higher consolidated profits in Q1 2025 Updated 6/3/2025 10:27:00 AM